# Matrix Therapy And Bacterial Keratitis

> **NCT02016989** · NA · UNKNOWN · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 60 (estimated)

## Conditions studied

- Bacterial Keratitis

## Interventions

- **DEVICE:** RGTA OTR4120 (CACICOL20)
- **DEVICE:** physiological salt solution

## Key facts

- **NCT ID:** NCT02016989
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-11
- **Primary completion:** 2014-09
- **Final completion:** 2014-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2013-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02016989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02016989, "Matrix Therapy And Bacterial Keratitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02016989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*